Search clinical trials for: UGN-102

Total 2101 results

Jiangsu HengRui Medicine Co., Ltd.

Completed

The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject

Diabetes

China
Ironwood Pharmaceuticals, Inc.

Completed

A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects

Healthy Volunteers

United States
Jazz Pharmaceuticals

Active, not recruiting

A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants

Healthy Participants

United States
Shanghai SIMR Biotechnology Co., Ltd.

Completed

The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers

Healthy

China
Insmed Incorporated

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants

Healthy Volunteers

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

To Compare the Pharmacokinetics and Pharmacodynamics of HR20014, INS068 and INS062 After Single Subcutaneous Injection in Healthy Subjects

Diabetes

China
University of Alberta

Active, not recruiting

Multidisciplinary Team IntervenTion in CArdio-ONcology (TITAN Study) (TITAN)

Breast Cancer

Canada
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors

Advanced Solid Tumors

China
Shanghai SIMRD Biotechnology Co., Ltd.

Completed

The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers

Healthy

China
Haisco Pharmaceutical Group Co., Ltd.

Completed

Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers

Healthy Volunteers

China
Palladio Biosciences

Completed

The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

Autosomal Dominant Polycystic Kidney Disease

United States
Akeso

Active, not recruiting

A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors

Solid Tumor, Adult

China
PharmaEssentia

Completed

The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection

Hepatitis C, Chronic

Taiwan
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of SHR4010 in Patients With Hemodialysis

Pruritus

China
SIMR (Australia) Biotech Pty Ltd.

Completed

A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419

Peripheral Neuropathic Pain

Australia
Institut Pasteur
The University of Hong Kong; University of Lausanne; University of Lausanne Hospitals and other collaborators

Terminated

Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia

Microcephaly | Congenital Infection

Sri Lanka, Vietnam, Cameroon, China, Côte D'Ivoire
CStone Pharmaceuticals

Completed

A Study of CS1001 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
Daewon Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

Osteoarthritis | Rheumatoid Arthritis | Back Pain | Acute Upper Respiratory Tract Infection

Korea, Republic of
PharmaEssentia

Completed

Single Dose Escalation Study of P1101 in Healthy Adult Male Subjects

Healthy Volunteers

Canada
Sarepta Therapeutics, Inc.

Completed

Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping

Duchenne Muscular Dystrophy

Belgium, France, Italy, United Kingdom
KalVista Pharmaceuticals, Ltd.

Completed

Phase 1 Crossover Study in Healthy Subjects to Evaluate the PK Profile of KVD824 Following Single and Multiple Doses of Modified Release (MR) Formulations

Hereditary Angioedema

United Kingdom
Jazz Pharmaceuticals

Completed

A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Hematologic Malignancy

United States, Canada
Shire

Completed

Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects

Hypoparathyroidism

United States
Vyne Therapeutics Inc.

Completed

A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

Prurigo Nodularis

Germany
NKGen Biotech, Inc.

Withdrawn

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Sarcoma | Cervical Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | EGF-R Positive Non-Small... and other conditions
Molnlycke Health Care AB
BioScience Laboratories, Inc.

Completed

Evaluation of the Residual Antimicrobial Efficacy of One Test Material Based on a Modification of ASTM E1115-11 Test Method

Hand Hygiene

United States
Incuron

Terminated

Study of IV CBL0137 in Previously Treated Hematological Subjects

Hematological Malignancies

United States
Spero Therapeutics

Completed

Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function

Renal Impairment

United States
Arthrosi Therapeutics

Completed

Multiple Ascending Dose Study of AR882 in Healthy Adult Male Volunteers

Healthy Volunteers

Australia
Lantheus Medical Imaging

Completed

A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress

Healthy Volunteers

United States
The University of Hong Kong

Completed

Parathyroidectomy in Endstage Renal Disease

Endstage Renal Disease

Hong Kong
Kirilys Therapeutics, Inc.

Completed

Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects

Healthy Volunteer

United States
Frontier Biotechnologies Inc.

Completed

Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects

Chronic Low Back Pain

China
PharmaEssentia Japan K.K.
PharmaEssentia

Completed

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics Study of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects

Healthy Volunteers

Australia
Tragara Pharmaceuticals, Inc.

Completed

Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Solsys Medical LLC

Completed

Multi Center Site , Controlled Trial Comparing a Bioengineered Skin Substitute to a Human Skin Allograft

Diabetic Foot Ulcer

United States
Mirum Pharmaceuticals, Inc.

Completed

A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One Dose

Non-Alcoholic Steatohepatitis

United States
Hanlim Pharm. Co., Ltd.

Unknown

A Multiple Dose of HL237 in Healthy Male Subject

Rheumatoid Arthritis

Korea, Republic of
Ra Medical Systems

Completed

Evaluating Plaque Photoablation Using an Excimer Laser in Patients With Lower Extremity Vascular Disease

Peripheral Arterial Disease

United States
ViaCyte

Completed

A Safety and Tolerability Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Canada
Chulalongkorn University

Completed

The Effect of Dexmedetomidine Infusion on Post-operative Cognitive Function and Oxidative Stress in Cardiac Surgery

Cognition Disorders | Oxidative Stress
Ulthera, Inc

Completed

Evaluation of the Effectiveness and Safety of the Ulthera™ System for the Treatment of Wrinkles Around the Eyes

Periorbital Wrinkles

United States
Chang Gung Memorial Hospital

Completed

Silicone Gel in the Treatment of Cleft Lip Scars

Cleft Lip

Taiwan
Community Research Initiative of New England
Bristol-Myers Squibb; Merck Sharp & Dohme LLC

Completed

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated. (BATAR)

HIV

United States
Theranexus
Institut de recherche biomédicale des armées (IRBA), Bretigny sur Orge, France

Completed

Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation

Sleep Deprivation
BioCryst Pharmaceuticals

Completed

An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates

Hereditary Angioedema

United Kingdom
Chang Gung Memorial Hospital

Completed

The Role of C-11 Choline PET in Patients With Prostate Cancer

Latent Cancer Prostate
Chang Gung Memorial Hospital
Chang Gung University

Completed

Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss

Zinc Deficiency | Hearing Loss, Noise-Induced | Tinnitus, Noise Induced
Yuhan Corporation

Completed

Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation

Functional Constipation

Korea, Republic of
Replicor Inc.

Completed

Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients

Hepatitis B, Chronic

Bangladesh

3

Subscribe